Loading company
Abbott Laboratories
ABT · NYSE · ·
Next earnings: October 21, 2026
$100.960.0%Sep 29 close
- 1M
- -10.2%
- 6M
- +0.4%
- 1Y
- -22.9%
- 5Y
- -7.7%
Abbott makes and sells medicines, diagnostic tests, nutrition products, and medical devices.
ABT · NYSE · ·
Next earnings: October 21, 2026
$100.960.0%Sep 29 close
Abbott makes and sells medicines, diagnostic tests, nutrition products, and medical devices.
Abbott Laboratories is scheduled to report next on October 21, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending March 31, 2026, against the same quarter a year earlier.
| Measure | 3 months toMar 31, 2026 | 3 months toMar 31, 2025 | Change |
|---|---|---|---|
| Total Revenue | $11.2B | $10.4B | +7.78% |
| Profit | $1.1B | $1.3B | -18.72% |
| Profit per share | $0.61 | $0.76 | -19.74% |
| Free Cash Flow | $916M | $933M | -1.82% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Releases land after the close or before the open, so the move is the session that follows.
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com and on LinkedIn , Facebook , Instagram , X and YouTube . Abbott will live-webcast its second-quarter earnings conference call through its
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Abbott Laboratories’s Item 2.02 8-K filed July 16, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
A short summary of each call — what the quarter showed, what management expects and whether they delivered on what they said last time — with the full transcript underneath.
Source: Yahoo Finance, transcribed by Quartr. Speaker names and roles are as transcribed; analysts are sometimes unnamed.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.
Call summaries are part of Pro
A two-minute read of every Abbott Laboratories earnings call: the numbers that mattered, what management expects, whether they delivered on last quarter’s outlook, and what analysts asked that went unanswered.
See one first on , , or — open to everyone.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.